Sarcopenic obesity definitions and their associations with physical frailty in older Brazilian adults: data from the SARCOS study.


Journal

Archives of endocrinology and metabolism
ISSN: 2359-4292
Titre abrégé: Arch Endocrinol Metab
Pays: Brazil
ID NLM: 101652058

Informations de publication

Date de publication:
30 Mar 2023
Historique:
medline: 5 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: ppublish

Résumé

To identify the obesity diagnosis with the highest association with physical frailty associated with sarcopenia EWGSOP II (sarcopenic obesity). We performed a cross-sectional analysis of 371 community-dwelling older adults. Appendicular skeletal lean mass and total body fat (TBF) were assessed using dual-energy x-ray absorptiometry, and physical frailty was defined using Fried's criteria. The phenotypes were identified according to the presence of sarcopenia by EWGSOP II and obesity, which was diagnosed using two concepts: BMI obesity (BMI ≥ 30 kg/m The mean age was 78.15 ± 7.22 years. Sarcopenia EWGSOP II was diagnosed in 19.8% (n = 73), body mass index obesity was identified in 21.8% (n = 81), TBF obesity was identified in 67.7% (n = 251), and physical frailty was identified in 38.5% (n = 142). In a regression analysis for frailty, sarcopenic TBF obesity presented an odds ratio of 6.88 (95% confidence interval 2.60-18.24; p < 0.001). In older Brazilian adults, sarcopenic obesity diagnosed by TBF obesity has a robust association with frailty and is independent of body mass index.

Identifiants

pubmed: 37011371
pii: 2359-3997000000587
doi: 10.20945/2359-3997000000587
pmc: PMC10247246
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-371

Références

Int J Obes Relat Metab Disord. 1993 Apr;17(4):197-203
pubmed: 8387968
AIDS. 2018 Jun 19;32(10):1257-1266
pubmed: 29794494
Am J Clin Nutr. 1997 Mar;65(3):855-60
pubmed: 9062540
Clin Geriatr Med. 2008 Aug;24(3):455-69, vi
pubmed: 18672182
J Am Geriatr Soc. 2008 Apr;56(4):689-94
pubmed: 18266843
Immun Ageing. 2015 Aug 04;12:9
pubmed: 26244048
Nutr Res. 2015 Dec;35(12):1031-9
pubmed: 26472145
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Am J Occup Ther. 1995 Jul-Aug;49(7):637-44
pubmed: 7573334
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Am Geriatr Soc. 2014 Feb;62(2):253-60
pubmed: 24428349
Int J Obes Relat Metab Disord. 1994 Jan;18(1):61-7
pubmed: 8130817
Nutrients. 2019 Jun 08;11(6):
pubmed: 31181771
J Gerontol A Biol Sci Med Sci. 2011 Mar;66(3):341-8
pubmed: 21310808
Nat Rev Endocrinol. 2018 Sep;14(9):513-537
pubmed: 30065268
Med Sci Sports Exerc. 1997 Mar;29(3):362-9
pubmed: 9139175
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Front Endocrinol (Lausanne). 2019 Apr 24;10:255
pubmed: 31068903
Prev Med. 2016 Oct;91:264-272
pubmed: 27575317
Int J Obes Relat Metab Disord. 2004 Feb;28(2):234-41
pubmed: 14708033
J Nutr Health Aging. 2009 May;13(5):460-6
pubmed: 19390754
Am J Clin Nutr. 2009 Jun;89(6):1895-900
pubmed: 19369381
Am J Transplant. 2019 Nov;19(11):3155-3161
pubmed: 31278829
Intern Med. 2011;50(22):2767-73
pubmed: 22082888
J Bone Miner Metab. 2017 Sep;35(5):554-561
pubmed: 27837272
Age Ageing. 2017 May 1;46(3):413-420
pubmed: 27932368
J Clin Densitom. 2013 Jul-Sep;16(3):360-367
pubmed: 23452872
Lancet Diabetes Endocrinol. 2018 Dec;6(12):944-953
pubmed: 30389323
Eur J Epidemiol. 2018 Sep;33(9):831-845
pubmed: 29524110
Innov Aging. 2017 Aug 30;1(1):igx008
pubmed: 30480107
Curr Diabetes Rev. 2006 Nov;2(4):367-73
pubmed: 18220642
J Nutr Health Aging. 2019;23(9):771-787
pubmed: 31641726
Int J Obes Relat Metab Disord. 2001 May;25(5):676-81
pubmed: 11360150
J Ren Nutr. 2013 Sep;23(5):356-62
pubmed: 23648049
Maturitas. 2017 Feb;96:10-15
pubmed: 28041587
Obesity (Silver Spring). 2009 Nov;17(11):2082-8
pubmed: 19373219
Heart. 2017 Feb;103(3):184-189
pubmed: 27940967
Ageing Res Rev. 2017 May;35:63-73
pubmed: 28143778
Eur J Clin Nutr. 2021 Mar;75(3):446-455
pubmed: 32948866

Auteurs

Alberto Frisoli (A)

Ambulatório de Cardiologia Geriátrica, Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Grupo de Pesquisa em Vulnerabilidade a Doenças do Idoso - Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Divisão de Cardiologia, Faculdade de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil, frisoli@uol.com.br.

Gustavo Duque (G)

Australian Institute for Musculoskeletal Science, Melbourne Medical School, University of Melbourne, Victoria, Australia.

Angela T Paes (AT)

Departamento de Estatística, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Amanda Rocha Diniz (AR)

Ambulatório de Cardiologia Geriátrica, Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Grupo de Pesquisa em Vulnerabilidade a Doenças do Idoso - Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Divisão de Cardiologia, Faculdade de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Eliene Lima (E)

Ambulatório de Cardiologia Geriátrica, Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Grupo de Pesquisa em Vulnerabilidade a Doenças do Idoso - Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Elaine Azevedo (E)

Ambulatório de Cardiologia Geriátrica, Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Grupo de Pesquisa em Vulnerabilidade a Doenças do Idoso - Divisão de Cardiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Divisão de Cardiologia, Faculdade de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Valdir Ambrósio Moises (VA)

Divisão de Cardiologia, Faculdade de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH